Health Care & Life Sciences » Biotechnology | Benitec Biopharma Ltd.

Benitec Biopharma Ltd. | Key People and Executives

Jerel A. Banks
Executive Chairman
Megan Boston
Executive Director
Peter Francis
Non-Executive Director
J. Kevin Buchi
Independent Non-Executive Director
Jerel A. Banks
Executive Chairman
Bryan Dulhunty
Chief Financial Officer
Georgina H. Kilfoil
Chief Clinical & Development Operations Officer
Megan Boston
Executive Director
Peter Francis
Non-Executive Director
Oliver Kidd
Co-Secretary
Gregory C. West
Co-Secretary
J. Kevin Buchi
Independent Non-Executive Director

About Benitec Biopharma

View Profile
Address
99 Mount Street
North Sydney New South Wales (NSW) 2060
Australia
Employees -
Website http://www.benitec.com
Updated 07/08/2019
Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene silencing technology called ddRNAi. It develops treatments for chronic and life threatening human conditions, such as oculopharyngeal muscular dystrophy, oncology, wet age-related macular degeneration, and hepatitis B. It operates through the Australia and USA geographical segments.